Researchers of Sechenov University, a Project 5-100 participant, together with their colleagues from Australia used the microfluidics technology to develop a device able to isolate cancer cells from urine of patients with prostate cancer. The study showed high sensitivity and specificity of the new method in diagnosing prostate cancer. The results obtained were published in...
by Ali Howard, University of Glasgow Scientists at the University of Glasgow and Cancer Research UK Beatson Institute have tested close to 1000 existing medicines and discovered that a cheap drug commonly used to treat parasitic worm infection could be a game-changing treatment for prostate cancer. Prostate cancer is the most common cancer affecting men...
by Institute of Cancer Research A pioneering precision medicine already licensed for breast and ovarian cancer can also slow or stop tumour growth in some men with advanced prostate cancer, a new clinical trial shows. The phase II trial found that over 80 per cent of men with prostate cancer whose tumours had mutations in...
(HealthDay)—Current statin use is inversely associated with the risk for lethal prostate cancer, according to a study published online Nov. 21 in Clinical Cancer Research. Emma H. Allott, Ph.D., from Queen’s University Belfast in the United Kingdom, and colleagues prospectively examined statin use and lethal prostate cancer risk in the Health Professionals Follow-up Study. Data...
UNIVERSITY OF EAST ANGLIA A simple urine test under development for prostate cancer detection can now use urine samples collected at home – according to new research from University of East Anglia and the Norfolk and Norwich University Hospital. Scientists pioneered the test which diagnoses aggressive prostate cancer and predicts whether patients will require treatment...
by American Association for Cancer Research Credit: CC0 Public Domain Commercial gene expression tests that guide treatment decisions for prostate cancer may not accurately predict risk of disease progression in African American patients, according to results published in Cancer Epidemiology, Biomarkers, and Prevention, a journal of the American Association for Cancer Research. “When a man is diagnosed with low-...
MEDICAL COLLEGE OF GEORGIA AT AUGUSTA UNIVERSITY AUGUSTA, Ga. (Nov. 13, 2019) – A transcription factor that aids neuron function also appears to enable a cell conversion in the prostate gland that can make an already recurrent cancer even more deadly, scientists say. BRN4 is mostly expressed in the central nervous system and inner ear,...
(HealthDay)—Men exposed to antidiabetic medications do not have different prostate-specific antigen (PSA) levels, and prostate cancer detection rates at biopsy do not differ regardless of trigger PSA levels, according to a study published online Nov. 6 in JAMA Network Open. Kerri Beckmann, Ph.D., from King’s College London, and colleagues examined the correlations of antidiabetic medication...
by National Cancer Research Institute Men with higher levels of ‘free’ testosterone and a growth hormone in their blood are more likely to be diagnosed with prostate cancer, according to research presented at the 2019 NCRI Cancer Conference. Other factors such as older age, ethnicity and a family history of the disease are already known...
by American Osteopathic Association A high consumption of dairy products, like milk and cheese, appears to be associated with an increased risk of prostate cancer, according to research published in the Journal of the American Osteopathic Association. Researchers note that prior studies have shown dairy products are the primary source of calcium in Western countries, where rates of...
